Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125275752 | 12527575 | 2 | F | 2014 | 20160719 | 20160705 | 20160722 | EXP | US-ROCHE-1787222 | ROCHE | 57.23 | YR | M | Y | 0.00000 | 20160722 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125275752 | 12527575 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | SOLUTION FOR INJECTION | /month | ||||||||
| 125275752 | 12527575 | 2 | C | CIALIS | TADALAFIL | 1 | 0 | ||||||||||||
| 125275752 | 12527575 | 3 | C | INSULIN | INSULIN NOS | 1 | Unknown | 0 | |||||||||||
| 125275752 | 12527575 | 4 | C | DIOVAN | VALSARTAN | 1 | Oral | 0 | 160 | MG | CAPSULE | ||||||||
| 125275752 | 12527575 | 5 | C | AMLODIPINE BESILATE/ATORVASTATIN CALCIUM | AMLODIPINE BESYLATEATORVASTATIN CALCIUM | 1 | Oral | 10/10 MG | 0 | TABLET | |||||||||
| 125275752 | 12527575 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 125275752 | 12527575 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | 100 UNITS/ML | 0 | SOLUTION FOR INJECTION | |||||||||
| 125275752 | 12527575 | 8 | C | COREG | CARVEDILOL | 1 | Oral | 0 | 25 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125275752 | 12527575 | 1 | Macular degeneration |
| 125275752 | 12527575 | 2 | Chronic obstructive pulmonary disease |
| 125275752 | 12527575 | 3 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125275752 | 12527575 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125275752 | 12527575 | Aneurysm | |
| 125275752 | 12527575 | Bladder cancer | |
| 125275752 | 12527575 | Cataract | |
| 125275752 | 12527575 | Haemorrhage | |
| 125275752 | 12527575 | Haemorrhage urinary tract | |
| 125275752 | 12527575 | Haemorrhoids | |
| 125275752 | 12527575 | Lenticular opacities | |
| 125275752 | 12527575 | Urinary bladder haemorrhage | |
| 125275752 | 12527575 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125275752 | 12527575 | 1 | 2014 | 2014 | 0 | |
| 125275752 | 12527575 | 3 | 201404 | 0 |